Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Emergency cardiac surgery in patients with acute coronary syndromes: a review of the evidence and perioperative implications of medical and mechanical therapeutics.

Brown C, Joshi B, Faraday N, Shah A, Yuh D, Rade JJ, Hogue CW.

Anesth Analg. 2011 Apr;112(4):777-99. doi: 10.1213/ANE.0b013e31820e7e4f. Epub 2011 Mar 8. Review.

2.

Antiplatelet intervention in acute coronary syndrome.

Arora RR, Rai F.

Am J Ther. 2009 Sep-Oct;16(5):e29-40. doi: 10.1097/MJT.0b013e31804c7238. Review.

PMID:
19092648
3.

Patients with non-ST-elevation acute coronary syndromes undergoing coronary artery bypass grafting in the modern era of antithrombotic therapy.

Chew DP, Huang Z, Pieper KS, White H, Mahaffey KW, Ferguson JJ, Califf RM, Aylward PG.

Am Heart J. 2008 Feb;155(2):239-44. doi: 10.1016/j.ahj.2007.10.002. Epub 2007 Nov 26.

PMID:
18215592
4.

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

Whellan DJ, Tricoci P, Chen E, Huang Z, Leibowitz D, Vranckx P, Marhefka GD, Held C, Nicolau JC, Storey RF, Ruzyllo W, Huber K, Sinnaeve P, Weiss AT, Dery JP, Moliterno DJ, Van de Werf F, Aylward PE, White HD, Armstrong PW, Wallentin L, Strony J, Harrington RA, Mahaffey KW.

J Am Coll Cardiol. 2014 Mar 25;63(11):1048-57. doi: 10.1016/j.jacc.2013.10.048. Epub 2013 Nov 21.

6.

Tailored antithrombotic therapy for acute coronary syndromes.

Fitchett D.

Expert Rev Cardiovasc Ther. 2008 Aug;6(7):935-44. doi: 10.1586/14779072.6.7.935. Review.

PMID:
18666844
7.

Acute coronary syndromes: advances in antithrombotics.

Gukathasan N, Mehran R.

Curr Atheroscler Rep. 2013 Apr;15(4):318. doi: 10.1007/s11883-013-0318-8. Review.

PMID:
23456409
8.

Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.

Roe MT, Goodman SG, Ohman EM, Stevens SR, Hochman JS, Gottlieb S, Martinez F, Dalby AJ, Boden WE, White HD, Prabhakaran D, Winters KJ, Aylward PE, Bassand JP, McGuire DK, Ardissino D, Fox KA, Armstrong PW.

Circulation. 2013 Aug 20;128(8):823-33. doi: 10.1161/CIRCULATIONAHA.113.002303. Epub 2013 Jul 12.

PMID:
23852610
9.

Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(5):1-70. Epub 2006 Mar 1.

10.

Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.

Manoukian SV.

Am J Cardiol. 2009 Sep 7;104(5 Suppl):9C-15C. doi: 10.1016/j.amjcard.2009.06.020. Review.

PMID:
19695355
11.

API expert consensus document on management of ischemic heart disease.

Association of Physicians of India.

J Assoc Physicians India. 2006 Jun;54:469-80. Review.

PMID:
16909697
12.

A risk score to predict bleeding in patients with acute coronary syndromes.

Mehran R, Pocock SJ, Nikolsky E, Clayton T, Dangas GD, Kirtane AJ, Parise H, Fahy M, Manoukian SV, Feit F, Ohman ME, Witzenbichler B, Guagliumi G, Lansky AJ, Stone GW.

J Am Coll Cardiol. 2010 Jun 8;55(23):2556-66. doi: 10.1016/j.jacc.2009.09.076.

13.

Antiplatelet therapy: anti-ischemic benefits versus bleeding risk.

Gibson CM.

J Interv Cardiol. 2008 Dec;21 Suppl 1:S3-9. doi: 10.1111/j.1540-8183.2008.00407.x. Review.

PMID:
19090934
14.

On-pump versus off-pump surgical revascularization in patients with acute coronary syndromes: analysis from the Acute Catheterization and Urgent Intervention Triage Strategy trial.

Ben-Gal Y, Stone GW, Smith CR, Williams MR, Weisz G, Stewart AS, Takayama H, Genereux P, Argenziano M.

J Thorac Cardiovasc Surg. 2011 Aug;142(2):e33-9. doi: 10.1016/j.jtcvs.2011.03.022. Epub 2011 Apr 29.

15.

Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting.

Beiras-Fernandez A, Kowert A, Jiru P, Weis M, Spannagl M, Reichart B, Schmoeckel M.

Ann Thorac Surg. 2009 Feb;87(2):629-31. doi: 10.1016/j.athoracsur.2008.06.040.

PMID:
19161801
16.

Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery.

Savonitto S, Caracciolo M, Cattaneo M, DE Servi S.

J Thromb Haemost. 2011 Nov;9(11):2133-42. doi: 10.1111/j.1538-7836.2011.04456.x. Review.

17.

Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention.

Pham PA, Pham PT, Pham PC, Miller JM, Pham PM, Pham SV.

Vasc Health Risk Manag. 2011;7:551-67. doi: 10.2147/VHRM.S23862. Epub 2011 Aug 26. Review.

18.

Relative importance of benefits and risks associated with antithrombotic therapies for acute coronary syndrome: patient and physician perspectives.

Yuan Z, Levitan B, Burton P, Poulos C, Brett Hauber A, Berlin JA.

Curr Med Res Opin. 2014 Sep;30(9):1733-41. doi: 10.1185/03007995.2014.921611. Epub 2014 Jun 2.

PMID:
24827068
19.

Dual antiplatelet therapy with aspirin and clopidogrel: what is the risk in noncardiac surgery? A narrative review.

Finkel JB, Marhefka GD, Weitz HH.

Hosp Pract (1995). 2013 Feb;41(1):79-88. doi: 10.3810/hp.2013.02.1013. Review.

PMID:
23466970
20.

Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome.

Packard KA, Campbell JA, Knezevich JT, Davis EM.

Pharmacotherapy. 2012 Mar;32(3):244-73. doi: 10.1002/j.1875-9114.2012.01021.x. Review.

PMID:
22392457

Supplemental Content

Support Center